Your browser doesn't support javascript.
loading
Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.
Chiloiro, Sabrina; Mazziotti, Gherardo; Giampietro, Antonella; Bianchi, Antonio; Frara, Stefano; Mormando, Marilda; Pontecorvi, Alfredo; Giustina, Andrea; De Marinis, Laura.
Afiliação
  • Chiloiro S; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
  • Mazziotti G; Endocrine Unit, ASST Carlo Poma, Mantua, Italy.
  • Giampietro A; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
  • Bianchi A; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
  • Frara S; Vita-Salute San Raffaele University, Milan, Italy.
  • Mormando M; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
  • Pontecorvi A; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
  • Giustina A; Vita-Salute San Raffaele University, Milan, Italy.
  • De Marinis L; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy. laurademarinis@yahoo.it.
Pituitary ; 21(3): 309, 2018 06.
Article em En | MEDLINE | ID: mdl-29473124
ABSTRACT
The original version of the article contained an error in the results section of the Abstract. The vertebral fractures (VFs) odds ratio is incorrectly published as 61.0 and the correct value is 6.10.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article